Neoplasms: all 9,610 studies
Page 92 of 97. Open to participants first (2,508), then studies with results posted, then the rest; newest registration first within each.
- A Study of the Safety and Effects of ADH-1 Given Daily to Subjects With Solid TumorsTerminatedNCT00225550Phase 1/2
- Prospective and Randomized Study to Evaluate Interest of Ultracision Use in Inguinal Lymph Nodes CurageCompletedNCT00224744Phase 3
- Vorinostat With or Without Isotretinoin in Treating Young Patients With Recurrent or Refractory Solid Tumors, Lymphoma, or LeukemiaCompletedNCT00217412Phase 1
- Study of XL184 (Cabozantinib) in Adults With Advanced MalignanciesCompletedNCT00215605Phase 1
- Capecitabine or 5-Fluorouracil in Combination With Irinotecan and Cisplatin in Patients With Solid Tumor MalignanciesCompletedNCT00215501Phase 1
- Trial of Levofloxacin as Prophylaxis After Allogeneic Stem Cell Transplantation (SCT)Status unknownNCT00215007Phase 2/3
- An Open-Label Study of the Safety and Efficacy of Atiprimod Treatment for Patients With Advanced CancerStatus unknownNCT00214838Phase 1/2
- ONO-7436 Phase II Study in JapanCompletedNCT00212602Phase 2
- Optimisation and Performance of Reduced Preparation CT ColographyCompletedNCT00212433Phase 4
- An Efficacy and Safety Study for Epoetin Alfa (PROCRIT) in Cancer Patients Not Receiving Chemotherapy or RadiationCompletedNCT00210587Phase 3
- Allogeneic Bone Marrow Transplantation With Matched Unrelated Donors for Patients With Hematologic MalignanciesCompletedNCT00208923Phase 2
- The Survey About Resting Metabolic Rate and Its Related Factors in Terminal PatientsCompletedNCT00208013
- 18F-fluorodeoxyglucose (18F-FDG) Positron Emission Tomography in OncologyCompletedNCT00207298
- Effect of Capecitabine on the Pharmacokinetics of BMS-247550 and BMS-247550 on the Pharmacokinetics of Capecitabine and Its Metabolites in Patients With Advanced MalignanciesCompletedNCT00207129Phase 1
- A Phase I Study of BMS-275183 Given on a Daily Schedule in Patients With Advanced MalignanciesTerminatedNCT00207025Phase 1
- MAD Refractory: Solid Tumor QD w/o BreakCompletedNCT00207012Phase 1
- Haploidentical Transplantation With CD3/CD19 Depleted Grafts in Patients With Hematologic MalignanciesCompletedNCT00202917Phase 1/2
- Phase I & Biological Study of Etanercept & Weekly Docetaxel in Patients With Advanced Solid TumorsCompletedNCT00201812Phase 1
- A Multi-center Survey of HPV in Cervical Intraepithelial Neoplasia (CIN) With Longitudinal Follow-up of LSIL CasesCompletedNCT00201370
- Hypertonic Saline 75% vs Mannitol 20%CompletedNCT00199511Not applicable
- Iron Therapy in Colo-Rectal Neoplasm and Iron Deficiency Anemia: Intravenous Iron Sucrose Versus Oral Ferrous Sulphate.Status unknownNCT00199277Phase 4
- Comparing Hepatic Intra-arterial Injection of Yttrium-90 Microspheres Versus Fluorouracil (5FU) in Colorectal Cancer Metastatic to the Liver OnlyCompletedNCT00199173Phase 3
- Study Evaluating TTI-237 in Advanced Malignant Solid Tumors.TerminatedNCT00195325Phase 1
- Study Evaluating TTI-237 in Advanced Malignant Solid TumorsTerminatedNCT00195247Phase 1
- Treatment With ATRA-IV and Depakote in Patients With Advanced Solid Tumor MalignanciesTerminatedNCT00195156Phase 1
- A Randomized Trial for Patients With Platinum Resistant Ovarian, Fallopian or Primary Peritoneal Cancer.CompletedNCT00191607Phase 3
- A Trial for Patients With Gestational Trophoblastic DiseaseCompletedNCT00190918Phase 2
- Combination Chemotherapy Consisting of Pegylated Liposomal Doxorubicin and Carboplatin in Malignant Gynecologic TumoursCompletedNCT00189410Phase 2
- Randomized, Multicenter, 2-Dose Level. Open-Label, Phase IIa Study With the Intraperitoneally Infused Trifunctional Bispecific Antibody Removab(TM) (Anti-EpCAM x Anti-CD3) to Select the Better Dose Level in Platinum Refractory Epithelial Ovarian Cancer PatientsCompletedNCT00189345Phase 2
- Combidex USPIO - Ultra-small Superparamagnetic Iron OxideCompletedNCT00188695Phase 1/2
- Intensity Modulated Radiation Therapy - Gyne Cancer (GY03.2)CompletedNCT00188578Phase 1/2
- Everolimus for Treating Pediatric Patients With Recurrent or Refractory TumorsCompletedNCT00187174Phase 1
- Study of ZD1839 Combined With Irinotecan and Vincristine in Pediatric Patients With Refractory Solid TumorsCompletedNCT00186979Phase 1
- Determination of a Safe Dose of Optison in Pediatric Patients With Solid TumorsCompletedNCT00186953Phase 1
- Haploidentical Stem Cell Transplantation for Patients With Hematologic MalignanciesCompletedNCT00186823Phase 3
- Proton MR Spectroscopy of Brain Metastases in Evaluation of Treatment Response.WithdrawnNCT00184288
- Characterization of Brain MetastasesCompletedNCT00184275
- Treatment of a Cancerous Disease of the Peritoneum With Complete Cytoreductive Surgery and Intraperitoneal ChemohyperthermiaTerminatedNCT00180960Phase 2
- Unmodified Versus Leuko-reduced Allogeneic Red Blood Cells Transfusion in Cancer PatientsCompletedNCT00180869Phase 3
- High Risk Primitive Neuroectodermal (PNET) Brain Tumors in ChildhoodStatus unknownNCT00180791Phase 2
- Thalomid and Carboplatin for the Treatment of Pediatric Brain Stem GliomaCompletedNCT00179881Phase 2
- Immunoablative Mini Transplant (Hematopoietic Peripheral Blood Stem Cell Transplant [HPBSC])CompletedNCT00179764Not applicable
- Mind-Body Program for Cancer PatientsCompletedNCT00179387Not applicable
- Chemotherapy With Whole Body Hyperthermia to Treat Resistant Breast, Endometrial, Cervical and Ovarian CancersStatus unknownNCT00178802Phase 2
- Feasibility of Treatment of Cancer Involving the Liver With High Dose RadiationCompletedNCT00178243Phase 1/2
- A Pilot Study of Lycopene Supplementation in Prostatic Intraepithelial NeoplasiaCompletedNCT00178113Phase 1
- Safety Study of S-CKD602 in Patients With Advanced MalignanciesCompletedNCT00177281Phase 1
- Dextromethorphan in Treating Patients With Fatigue Caused by CancerTerminatedNCT00176540Not applicable
- Imatinib Mesylate in Patients With Various Types of Malignancies Involving Activated Tyrosine Kinase EnzymesCompletedNCT00171912Phase 2
- SB-715992 In Combination With Docetaxel In Patients With Solid TumorsCompletedNCT00169520Phase 1
- A Phase I Open Label Study of E7974 Administered on a Day 1 of 21-Day Cycle In Patients With Advanced Solid TumorsCompletedNCT00165802Phase 1
- Dynamic Area Telethermometry (DAT) as an Imaging Modality in Patients With CancerCompletedNCT00165100Not applicable
- RCT to Investigate Whether an Exercise Programme Improves the Physical Performance and QOL After BMTStatus unknownNCT00163644Not applicable
- Study of Dasatinib in Patients With Advanced Solid TumorsTerminatedNCT00162214Phase 1
- Evaluation of Vasopressin in the Vessels of Ovarian NeoplasmsCompletedNCT00160472Not applicable
- Immediate Treatment vs Colposcopic Follow-up for Biopsy-Proven CIN 1CompletedNCT00156026Phase 3
- A Pilot Study of EM-1421 for the Treatment of Cervical Intraepithelial NeoplasiaCompletedNCT00154089Phase 1/2
- Stereotactic Radiotherapy (SRT) Liver (COLD 1)CompletedNCT00152906Phase 1/2
- Stem Cell Transplantation for Patients With Hematologic MalignanciesCompletedNCT00152139Phase 3
- Chemotherapy With CD133+ Select Autologous Hematopoietic Stem Cells for Children With Solid Tumors and LymphomasCompletedNCT00152126Not applicable
- Cell Therapy of Cancer With Allogeneic Blood Lymphocytes Activated With Recombinant Interleukin-2 (rIL-2) for Metastatic Solid TumorsStatus unknownNCT00149006Phase 2
- Allogeneic Tumor Cell Vaccination in Patients With Solid TumorsWithdrawnNCT00148993Phase 1/2
- Study for the Treatment of Anemia in Patients With Non-myeloid Malignancies Receiving Multicycle Chemotherapy.CompletedNCT00148421Phase 3
- MEK Inhibitor PD-325901 To Treat Advanced Breast Cancer, Colon Cancer, And Melanoma.TerminatedNCT00147550Phase 1/2
- A Phase 1 Study Of An Intravenously Administered Cyclin-Dependent Kinase Inhibitor In Patients With Advanced CancerTerminatedNCT00147485Phase 1
- Randomized Trial of Adjuvant Chemotherapy With Cisplatin Followed by UFT in Serosa-positive Gastric Cancer (JCOG9206-2)CompletedNCT00147147Phase 3
- The Role of Fluorothymidine Positron Emission Tomography (FLT-PET) in Proliferation of Colorectal Liver MetastasesTerminatedNCT00145665Phase 1/2
- Haploidentical Stem Cell Transplant for Treatment Refractory Hematological MalignanciesCompletedNCT00145613Phase 2
- Determination of Carboplatin's Optimal Plasmatic ExposureCompletedNCT00145028Not applicable
- Irinotecan Versus Only Best Supportive Care for Gastric CancerCompletedNCT00144378Phase 3
- Flexibility: A Study to Assess the Impact of Darbepoetin Alfa in Subjects withNon-Myeloid Malignancies With Anemia Due to ChemotherapyCompletedNCT00144131Phase 2
- Stem Cell Transplantation as Immunotherapy for Hematologic MalignanciesCompletedNCT00143559Phase 2
- Docetaxel and Capecitabine in Advanced Gastric CancerCompletedNCT00142038Phase 2
- A Pharmacokinetic Study of Erlotinib in Cancer Patients With Advanced Solid Tumors, With Adequate and Moderately Impaired Hepatic FunctionCompletedNCT00139620Phase 1
- Brain Metastases Study: Radiotherapy Fractionation Schemes in the Treatment of Brain MetastasesCompletedNCT00138788Phase 3
- Temozolomide, Vincristine, and Irinotecan in Treating Young Patients With Refractory Solid TumorsCompletedNCT00138216Phase 1
- Trial of Prophylactic Versus Empirical Vancomycin for the Prevention of Streptococcal Sepsis After Hematopoietic Cell TransplantationCompletedNCT00138112Phase 3
- Ispinesib In Combination With Carboplatin In Patients With Solid TumorsCompletedNCT00136578Phase 1
- SB-743921 In Patients With Solid TumorsCompletedNCT00136513Phase 1
- AIM 3: Anemia and Iron Management With Every 3 Week Dosing in Anemic Subjects With Nonmyeloid MalignanciesCompletedNCT00135317Phase 3
- Study of Motexafin Gadolinium for the Treatment of Renal Cell (Kidney) CancerCompletedNCT00134186Phase 2
- An Analysis of the Response of Human Tumor Microvascular Endothelium to Ionizing RadiationCompletedNCT00132704
- A Phase 1 Open-Label Study of E7974 Administered on Days 1 and 15 of a 28-Day Cycle in Patients With Solid MalignanciesCompletedNCT00130169Phase 1
- Study of Bavituximab in Patients With Advanced Solid Tumor MalignanciesCompletedNCT00129337Phase 1
- Ketoconazole Administration: How it is Affected by the Body and Broken Down and How it Acts on the Body When Used With VelcadeCompletedNCT00129207Phase 1
- MiniMUD Study - Unrelated Reduced Intensity Conditioning With Treosulfan® for Allogeneic Stem Cell Transplantation in Patients With Hematological MalignanciesStatus unknownNCT00129155Phase 2
- Study Evaluating Gefitinib (IRESSA®) in Subjects With Solid Malignancies That Are Locally Advanced, Recurrent or MetastaticCompletedNCT00127829Phase 1
- Investigating the Impact of Tailored Reports on Anxiety Amongst Cancer Patients and Their ConfidantsCompletedNCT00127465Phase 1/2
- Sorafenib and Erlotinib in Treating Patients With Metastatic or Unresectable Solid TumorsCompletedNCT00126620Phase 1
- Study of Oral Clofarabine Administered Daily for 5 Days in Adult Patients With Refractory Solid TumorsCompletedNCT00125827Phase 1
- A Trial Comparing Radiosurgery With Surgery for Solitary Brain MetastasesCompletedNCT00124761Phase 3
- Study of F-Fluorodeoxyglucose (FluGlucoScan) in Patients With Known or Suspected Cancers of Low IncidenceCompletedNCT00123773Phase 2
- Study of 18F-Fluorodeoxyglucose (FluGlucoScan) in Patients With Cancer or Suspected CancerCompletedNCT00123760Phase 2/3
- Clinical Trial of New Elastomer for Maxillofacial ProstheticsCompletedNCT00123097Phase 3
- An Open-Label Study of E7974 Administered on Days 1, 8, and 15 of a 28-Day Cycle and Days 1 and 8 of a 21-Day Cycle in Patients With Solid MalignanciesCompletedNCT00121732Phase 1
- Study of Motexafin Gadolinium With Whole Brain Radiation Therapy Followed by Stereotactic Radiosurgery Boost in the Treatment of Patients With Brain MetastasesTerminatedNCT00121420Phase 2
- SJG-136 in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed By SurgeryCompletedNCT00121290Phase 1
- Vorinostat and Capecitabine in Treating Patients With Metastatic or Unresectable Solid TumorsCompletedNCT00121277Phase 1
- 17-AAG and Sorafenib in Treating Patients With Unresectable or Metastatic Solid TumorsCompletedNCT00121264Phase 1
- Treatment for Patients With Gynecological Malignancies Who Suffer From Anemia Due to ChemotherapyCompletedNCT00121030Phase 2